19
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Skeletal muscle glucose uptake, glycogen synthase activity and GLUT 4 content during hypoglycaemia in type 1 diabetic subjects

Pages 371-381 | Published online: 08 Jul 2009

REFERENCES

  • DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977–86.
  • Bolli G, DeFeo P, Compagnucci P, Cartechini MG, Angeletti G, Santeusanio F, Brunetti P, Gerich JE. Abnormal glucose counterregulation in insulin-dependent diabetes mellitus: interaction of anti-insulin antibodies and impaired glucagon and epinephrine secretion. Diabetes 1983; 32: 134–41.
  • Gerich JE, Langlois M, Noacco C, Karam J, Forsham PH. Lack of a glucagon response to hypoglycemia in diabetes: evidence for an intrinsic pancreatic alpha cell defect. Science 1973; 182: 171–3.
  • White NH, Skor PA, Cryer PE, Levandorski LA, Bier DM, Santiago JV. Identification of type 1 diabetic patients at increased risk for hypoglycemia during intensive treatment. N Engl J Med 1983; 308: 485–91.
  • Amiel SA, Sherwin RS, Simonson DC, Tamborlane WV. Effect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone release. Diabetes 1988; 37: 901–7.
  • Rosen SG, Clutter WE, Berk MA, Shah SD, Cryer PE. Epinephrine supports the postabsorbtive plasma glucose concentration and prevents hypo-glycemia when glucagon secretion is deficient in man. J Clin Invest 1984; 405–11.
  • Cohen N, Rossetti L, Shlimovich P, Halberstam M, Hu M, Shamoon H. Counterregulation of hypogly-cemia; skeletal muscle glycogen metabolism during three hours of physiological hyperinsulinemia in humans. Diabetes 1995; 44: 423–30.
  • Capaldo BR, Napoli R, Guida R, Di Bonito P, Antoniello S, Auletta M, Pardo F, Rendina V, Sacca L. Forearm muscle insulin resistance during hypoglycemia: role of adrenergic mechanisms and hypoglycemia per se. Am J Physiol 1998; 268: E248–54.
  • Abildgaard N, Orskov L, Petersen JA, Alberti KG, Schmitz 0, Moller N. Forearm substrate exchange during hyperinsulinaemic hypoglycaemia in normal man. Diabet Med 1995; 12: 218–23.
  • Shamoon H, Friedman S, Canton C, Zaharowicz L, Hu M, Rossetti L. Increased epi-nephrine and skeletal muscle responses to hypogly-cemia in non-insulin-dependent diabetes mellitus. J Clin Invest 1994; 93: 2562–71.
  • Orskov L, Bak JF, Abildgärd N, Schmitz 0, Andreasen F, Richter EA, Skjwrbwk C, Moller N. Inhibition of muscle glycogen synthase activity and non-oxidative glucose disposal during hypoglyce-mia in normal man. Diabetologia 1996; 39: 226–34.
  • DeFronzo RA, Jacot E, Jequier E, Maeder E, Wahren J, Felber JP. The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes 1981; 30: 1000–7.
  • Sheperd PR, Kahn BB. Glucose transporters and insulin action. Implications for insulin resistance and diabetes mellitus. N Engl J Med 1999; 341: 248–57.
  • Cryer PE. Hypoglycemia: the limiting factor in the management of IDDM. Diabetes 1994; 43: 1378–87.
  • Finegood DT, Bergman RN, Vranic M. Estimation of endogenous glucose production during hyper-insulinemic-euglycemic glucose clamps. Compari-son of unlabeled and labeled exogenous glucose infusates. Diabetes 1987; 36: 914–24.
  • Frayn KN. Calculation of substrate oxidation rates in vivo from gaseous exchange. J Appl Physiol 1983; 55: 628–34.
  • Bak JF, Moller N, Schmitz 0. Effects of growth hormone on fuel utilization and muscle glycogen synthase activity in normal humans. Am J Physiol 1991; 260: E736–42.
  • Orskov H, Thomsen HG, Yde H. Wick chromato-graphy for rapid and reliable immunoassay of insulin, glucagon and growth hormone. Nature 1968;219: 193–5.
  • Andersen L, Dinesen B, Jorgensen PN, Poulsen F, Roder ME. Enzyme immunoassay for intact human insulin in serum or plasma. Clin Chem 1993; 39: 578–82.
  • Harrison J. Hodson AW, Skillen AW, Stappenbeck R, Agius L, Alberti KG. Blood glu-cose, lactate, pyruvate, glycerol, 3-hydroxybutyrate and acetoacetate measurements in man using a centrifugal analyser with a fluorimetric attachment. J Clin Chem Clin Biochem 1988; 26: 141–6.
  • Bak JF, Pedersen 0. Exercise-enhanced activation of glycogen synthase in human skeletal muscle. Am J Physiol 1990; 258: E957–63.
  • Pedersen 0, Bak JF, Andersen PH, Lund S, Moller DE, Flier JS, Kahn BB. Evidence against altered expression of GLUT1 or GLUT4 in skeletal muscle of patients with obesity or NIDDM. Diabetes 1990; 89: 865–70.
  • Cline GW, Petersen KF, Krssak M, Shen J, Hundal RS, Trajanoski Z, Inzucchi S, Dresner A, Rothman DL, Shulman GI. Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes. N Engl J Med 1999; 341: 240–6.
  • George E, Harris N, Bedford C, Macdonald IA, Hardisty CA, Heller SR. Prolonged but partial impairment of the hypoglycemic physiological response following short-term hypoglycemia in normal subjects. Diabetologia 1995; 38: 1183–90.
  • Cranston I, Lomas J, Maran A, Macdonald I, Amiel SA. Restoration of hypoglycaemia awareness in patients with long-duration insulin-dependent diabetes. Lancet 1994; 344: 283–7.
  • Thiebaud D, Jacot E, DeFronzo RA, Maeder E, Jequier E, Felber JP. The effect of graded doses of insulin on total glucose uptake, glucose oxidation, and glucose storage in man. Diabetes 1982; 31: 957–63.
  • Deibert DC, DeFronzo RA. Epinephrine-induced insulin resistance in man. J Clin Invest 1980; 65: 717–21.
  • Raz I, Katz A, Spencer MK. Epinephrine inhibits insulin-mediated glycogenesis but enhances gly-colysis in human skeletal muscle. Am J Physiol 1991; 260: E430–5.
  • Fritsche A, Stumvoll M, Haring HU, Gerich JE. Reversal of hypoglycemia unawareness in a long-term type 1 diabetic patient by improvement of beta-adrenergic sensitivity after prevention of hypoglycemia. J Clin Endocrinol Metab 2000; 85: 525–5.
  • Moller N, Butler PC, Antsiferov M, Alberti KGMM. Effects of growth hormone on insulin sensitivity and forearm metabolism in normal man. Diabetologia 1989; 32: 105–10.
  • Corderre L, Srivastava AS, Chiasson JL. Effect of hypercorticism on regulation of skeletal muscle glycogen metabolism by insulin. Am J Physiol 1992; 262: E427–33.
  • Rabinowitz D, Klassen GA, Zierler KL. Effect of human growth hormone on muscle and adipose tissue metabolism in the forearm of man. J Clin Invest 1965; 44: 51–61.
  • Divertie GD, Jensen MD, Miles JM. Stimulation of lipolysis in humans by physiological hypercorti-solemia. Diabetes 1991; 40: 1228–32.
  • Ottosson M, Lonnroth P, Bjorntorp P, Eden S. Effects of cortisol and growth hormone on lipolysis in human adipose tissue [In Process Citation]. J Clin Endocrinol Metab 2000; 85: 799–803.
  • Koivisto U-M, Martinez-Valdez H, Bilan PJ, Burdett E, Ramlal T, Klip A. Differential regu-lation of the GLUT-1 and GLUT-4 glucose trans-port systems by glucose and insulin in L6 muscle cells in culture. J Biol Chem 1998; 266: 2615–21.
  • Mathoo JMA, Shi ZQ, Klip A, Vranic M. Opposite effects of acute hypoglycemia and acute hyperglyce-mia on glucose transport and glucose transporters in perfused rat skeletal muscle. Diabetes 1999; 48: 1281–8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.